SE9302414L - Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid - Google Patents

Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid

Info

Publication number
SE9302414L
SE9302414L SE9302414A SE9302414A SE9302414L SE 9302414 L SE9302414 L SE 9302414L SE 9302414 A SE9302414 A SE 9302414A SE 9302414 A SE9302414 A SE 9302414A SE 9302414 L SE9302414 L SE 9302414L
Authority
SE
Sweden
Prior art keywords
peptide
alpha
pharmaceutical composition
composition containing
antagonist activity
Prior art date
Application number
SE9302414A
Other languages
Unknown language ( )
English (en)
Other versions
SE501678C2 (sv
SE9302414D0 (sv
Inventor
Carl-Johan Aurell
Per Melin
Anders Nilsson
Jerzy Trojnar
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Priority to SE9302414A priority Critical patent/SE501678C2/sv
Publication of SE9302414D0 publication Critical patent/SE9302414D0/sv
Priority to JP7504493A priority patent/JPH09502427A/ja
Priority to PL94312568A priority patent/PL312568A1/xx
Priority to CN94192763A priority patent/CN1126999A/zh
Priority to HU9503768A priority patent/HUT74874A/hu
Priority to CZ9698A priority patent/CZ9896A3/cs
Priority to AU72406/94A priority patent/AU676071B2/en
Priority to PCT/SE1994/000674 priority patent/WO1995002609A1/en
Priority to CA002163114A priority patent/CA2163114A1/en
Priority to EP94921875A priority patent/EP0791012A1/en
Priority to IL11026794A priority patent/IL110267A0/xx
Priority to ZA945090A priority patent/ZA945090B/xx
Priority to TW083107195A priority patent/TW268009B/zh
Publication of SE9302414L publication Critical patent/SE9302414L/sv
Publication of SE501678C2 publication Critical patent/SE501678C2/sv
Priority to KR1019950705294A priority patent/KR960702848A/ko
Priority to NO955059A priority patent/NO955059L/no
Priority to FI960119A priority patent/FI960119A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE9302414A 1993-07-13 1993-07-13 Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid SE501678C2 (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE9302414A SE501678C2 (sv) 1993-07-13 1993-07-13 Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
PL94312568A PL312568A1 (en) 1993-07-13 1994-07-07 Peptides having antagonistic action in relation to oxytocin
CA002163114A CA2163114A1 (en) 1993-07-13 1994-07-07 Peptides exhibiting oxytocin antagonistic activity
EP94921875A EP0791012A1 (en) 1993-07-13 1994-07-07 Peptides exhibiting oxytocin antagonistic activity
CN94192763A CN1126999A (zh) 1993-07-13 1994-07-07 具有催产素拮抗剂活性的肽类化合物
HU9503768A HUT74874A (en) 1993-07-13 1994-07-07 Peptides exhibiting oxytocin antagonistic activity and pharmaceutical compositions containing them as active component
CZ9698A CZ9896A3 (en) 1993-07-13 1994-07-07 Peptide suppressing oxytocin activity
AU72406/94A AU676071B2 (en) 1993-07-13 1994-07-07 Peptides exhibiting oxytocin antagonistic activity
PCT/SE1994/000674 WO1995002609A1 (en) 1993-07-13 1994-07-07 Peptides exhibiting oxytocin antagonistic activity
JP7504493A JPH09502427A (ja) 1993-07-13 1994-07-07 オキシトシン拮抗薬活性を示すペプチド
IL11026794A IL110267A0 (en) 1993-07-13 1994-07-11 Peptide exhibiting oxytocin antagonistic activity
ZA945090A ZA945090B (en) 1993-07-13 1994-07-13 Peptides exhibiting oxytocin antagonistic activity
TW083107195A TW268009B (sv) 1993-07-13 1994-08-05
KR1019950705294A KR960702848A (ko) 1993-07-13 1995-11-27 옥시토신 길항적 활성을 나타내는 펩티드
NO955059A NO955059L (no) 1993-07-13 1995-12-13 Peptider som utviser oksytocin antagonistisk aktivitet
FI960119A FI960119A (sv) 1993-07-13 1996-01-10 Peptider med oxitocin antagoniserande aktivitet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9302414A SE501678C2 (sv) 1993-07-13 1993-07-13 Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid

Publications (3)

Publication Number Publication Date
SE9302414D0 SE9302414D0 (sv) 1993-07-13
SE9302414L true SE9302414L (sv) 1995-01-14
SE501678C2 SE501678C2 (sv) 1995-04-10

Family

ID=20390606

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9302414A SE501678C2 (sv) 1993-07-13 1993-07-13 Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid

Country Status (16)

Country Link
EP (1) EP0791012A1 (sv)
JP (1) JPH09502427A (sv)
KR (1) KR960702848A (sv)
CN (1) CN1126999A (sv)
AU (1) AU676071B2 (sv)
CA (1) CA2163114A1 (sv)
CZ (1) CZ9896A3 (sv)
FI (1) FI960119A (sv)
HU (1) HUT74874A (sv)
IL (1) IL110267A0 (sv)
NO (1) NO955059L (sv)
PL (1) PL312568A1 (sv)
SE (1) SE501678C2 (sv)
TW (1) TW268009B (sv)
WO (1) WO1995002609A1 (sv)
ZA (1) ZA945090B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
JP4615221B2 (ja) 2002-02-27 2011-01-19 フェリング ベスローテン フェンノートシャップ ヘプタペプチドオキシトシンアナログを製造するための中間体及び方法
CN108290929A (zh) * 2015-10-06 2018-07-17 辉凌公司 制造巴芦西班及其中间体的新型方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5373089A (en) * 1988-09-02 1994-12-13 Northwestern University Oxytocin antagonist
SE9002384D0 (sv) * 1990-07-09 1990-07-09 Ferring Ab Derivat av baklobshormoner
SE501677C2 (sv) * 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel

Also Published As

Publication number Publication date
WO1995002609A1 (en) 1995-01-26
SE501678C2 (sv) 1995-04-10
EP0791012A1 (en) 1997-08-27
CN1126999A (zh) 1996-07-17
CA2163114A1 (en) 1995-01-26
KR960702848A (ko) 1996-05-23
ZA945090B (en) 1995-02-22
TW268009B (sv) 1996-01-11
FI960119A0 (sv) 1996-01-10
AU7240694A (en) 1995-02-13
JPH09502427A (ja) 1997-03-11
NO955059D0 (no) 1995-12-13
CZ9896A3 (en) 1996-06-12
HU9503768D0 (en) 1996-02-28
AU676071B2 (en) 1997-02-27
SE9302414D0 (sv) 1993-07-13
HUT74874A (en) 1997-02-28
FI960119A (sv) 1996-01-10
IL110267A0 (en) 1994-10-21
NO955059L (no) 1995-12-13
PL312568A1 (en) 1996-04-29

Similar Documents

Publication Publication Date Title
IL102848A0 (en) Polypeptides having growth hormone releasing activity,their use and pharmaceutical compositions containing them
DE3854159D1 (de) Effektive antagonisten für den das luteinisierende hormon freisetzenden faktor mit unbedeutender histaminfreisetzung.
MX9402339A (es) Formulacion de proteina.
DK0726768T3 (da) Anvendelse af nitrogenoxidfrigørende forbindelser til fremstillingen af et medikament til beskyttelse i iskæmisk reperfusio
MY139203A (en) Pharmaceutical composition
KR950701818A (ko) 탈-tyr 다이놀핀 동족체(des-tyr dynorphin analogues)
ATE39701T1 (de) Gnrh-antagonisten.
BR9710615A (pt) Uso de um agente na manufatura de um medicamento para o tratamento de doença metabólica óssea, e, agente de anti-absorção óssea.
NO955058D0 (no) Biologiske aktive vasopressinanaloger
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
SE9302414L (sv) Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
ATE6504T1 (de) Polypeptide.
DK1309613T3 (da) Farmaceutisk præparat omfattende et analgetisk peptid
ATE546461T1 (de) Gnrh analog von nicht-säugertieren und verwendung zur regulierung der fruchtbarkeit und der schwangerschaft
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
ATE364392T1 (de) Zusammensetzung aus liganden/lytischen petiden und ihre verwendung
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
ES2211996T3 (es) Agentes de union a receptores de acido hialuronico y su uso para el tratamiento de tumores o de reestenosis.
ES8701784A1 (es) Un procedimiento para preparar un peptido ciclico con acti- vidad antagonista de vasopresina
EP0225746A3 (en) Therapeutic decapeptides
ATE540968T1 (de) Alpha-fetoproteinpeptide und deren verwendungen
KR930012034A (ko) 급성 췌장염 치료용 브래디키닌-길항제
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
EP0307662A3 (en) Enkephalin analogs
ZA862570B (en) Therapeutic decapeptides

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9302414-9

Format of ref document f/p: F